Compass Pathways Plc (CMPS)
10.82
-0.80
(-6.88%)
USD |
NASDAQ |
Oct 16, 14:10
Compass Pathways SG&A Expense (TTM) : 68.79M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.79M |
| March 31, 2026 | 58.30M |
| December 31, 2025 | 60.72M |
| September 30, 2025 | 60.82M |
| June 30, 2025 | 62.81M |
| March 31, 2025 | 64.32M |
| December 31, 2024 | 59.18M |
| September 30, 2024 | 54.42M |
| June 30, 2024 | 51.76M |
| March 31, 2024 | 50.38M |
| December 31, 2023 | 49.58M |
| September 30, 2023 | 50.71M |
| June 30, 2023 | 49.71M |
| Date | Value |
|---|---|
| March 31, 2023 | 48.06M |
| December 31, 2022 | 45.19M |
| September 30, 2022 | 47.45M |
| June 30, 2022 | 45.51M |
| March 31, 2022 | 42.44M |
| December 31, 2021 | 39.18M |
| September 30, 2021 | 31.40M |
| June 30, 2021 | 28.48M |
| March 31, 2021 | 31.29M |
| December 31, 2020 | 28.03M |
| September 30, 2020 | 21.05M |
| June 30, 2020 | 14.45M |
| March 31, 2020 | 3.484M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Silence Therapeutics Plc | 21.27M |
| Biodexa Pharmaceuticals Plc | 5.629M |
| NuCana Plc | 7.064M |
| Mereo BioPharma Group Plc | 19.44M |
| HemoGenyx Pharmaceuticals Plc | 5.527M |